BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 19328792)

  • 1. The C-terminal cytoplasmic domain of human proEGF is a negative modulator of body and organ weights in transgenic mice.
    Klonisch T; Glogowska A; Gratao AA; Grzech M; Nistor A; Torchia M; Weber E; de Angelis MH; Rathkolb B; Cuong HV; Wolf E; Schneider MR
    FEBS Lett; 2009 Apr; 583(8):1349-57. PubMed ID: 19328792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic domain of proEGF affects distribution and post-translational modification of microtubuli and increases microtubule-associated proteins 1b and 2 production in human thyroid carcinoma cells.
    Pyka J; Glogowska A; Dralle H; Hoang-Vu C; Klonisch T
    Cancer Res; 2005 Feb; 65(4):1343-51. PubMed ID: 15735020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-binding EGF-like growth factor (HB-EGF) overexpression in transgenic mice downregulates insulin-like growth factor binding protein (IGFBP)-3 and -4 mRNA.
    Provenzano AP; Besner GE; James PF; Harding PA
    Growth Factors; 2005 Mar; 23(1):19-31. PubMed ID: 16019424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects on kidney and liver growth of a non-viral hGH-expression vector in hypophysectomized mice.
    Khamaisi M; Søndergaard M; Segev Y; Dagnaes-Hansen F; Jensen TG; Landau D; Raz I; Flyvbjerg A
    Growth Horm IGF Res; 2007 Aug; 17(4):279-87. PubMed ID: 17392003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytoplasmic domain of proEGF negatively regulates motility and elastinolytic activity in thyroid carcinoma cells.
    Glogowska A; Pyka J; Kehlen A; Los M; Perumal P; Weber E; Cheng SY; Hoang-Vu C; Klonisch T
    Neoplasia; 2008 Oct; 10(10):1120-30. PubMed ID: 18813355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
    Shimizu M; Shirakami Y; Iwasa J; Shiraki M; Yasuda Y; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
    Clin Cancer Res; 2009 May; 15(9):3068-75. PubMed ID: 19366832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fasting on IGF-I, IGF-II, and IGF-binding protein mRNA concentrations in channel catfish (Ictalurus punctatus).
    Peterson BC; Waldbieser GC
    Domest Anim Endocrinol; 2009 Aug; 37(2):74-83. PubMed ID: 19446983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice.
    Bielohuby M; Roemmler J; Manolopoulou J; Johnsen I; Sawitzky M; Schopohl J; Reincke M; Wolf E; Hoeflich A; Bidlingmaier M
    Exp Biol Med (Maywood); 2009 Aug; 234(8):1002-9. PubMed ID: 19491373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urothelial overexpression of insulin-like growth factor-1 increases susceptibility to p-cresidine-induced bladder carcinogenesis in transgenic mice.
    Hursting SD; Perkins SN; Lavigne JA; Beltran L; Haines DC; Hill HL; Alvord WG; Barrett JC; DiGiovanni J
    Mol Carcinog; 2009 Aug; 48(8):671-7. PubMed ID: 19415693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo.
    Buttgereit F; Zhou H; Kalak R; Gaber T; Spies CM; Huscher D; Straub RH; Modzelewski J; Dunstan CR; Seibel MJ
    Arthritis Rheum; 2009 Jul; 60(7):1998-2007. PubMed ID: 19565501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mouse model of ghrelinoma exhibited activated growth hormone-insulin-like growth factor I axis and glucose intolerance.
    Iwakura H; Ariyasu H; Li Y; Kanamoto N; Bando M; Yamada G; Hosoda H; Hosoda K; Shimatsu A; Nakao K; Kangawa K; Akamizu T
    Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E802-11. PubMed ID: 19602582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-expression profiles in mouse blood-plasma following acute whole-body exposure to (137)Cs gamma rays.
    Rithidech KN; Honikel L; Rieger R; Xie W; Fischer T; Simon SR
    Int J Radiat Biol; 2009 May; 85(5):432-47. PubMed ID: 19365744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human epidermal growth factor in human serum and urine under native conditions.
    Aybay C; Karakus R; Yucel A
    Cytokine; 2006 Jul; 35(1-2):36-43. PubMed ID: 16908178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells.
    Kim MS; Kim SY; Arunachalam S; Hwang PH; Yi HK; Nam SY; Lee DY
    Biochem Biophys Res Commun; 2009 Jul; 385(1):38-43. PubMed ID: 19427836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization, tissue distribution patterns and nutritional regulation of IGFBP-1, -2, -3 and -5 in yellowtail, Seriola quinqueradiata.
    Pedroso FL; Fukada H; Masumoto T
    Gen Comp Endocrinol; 2009 May; 161(3):344-53. PubMed ID: 19523384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice.
    Kalak R; Zhou H; Street J; Day RE; Modzelewski JR; Spies CM; Liu PY; Li G; Dunstan CR; Seibel MJ
    Bone; 2009 Jul; 45(1):61-7. PubMed ID: 19358901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of somatic growth, time of sexual maturity, and life expectancy by overexpression of an RGD-deficient IGFBP-2 variant in female transgenic mice.
    Hoeflich A; Reyer A; Ohde D; Schindler N; Brenmoehl J; Spitschak M; Langhammer M; Tuchscherer A; Wirthgen E; Renner-Müller I; Wanke R; Metzger F; Bielohuby M; Wolf E
    Aging Cell; 2016 Feb; 15(1):111-7. PubMed ID: 26507795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice.
    Kake T; Kitamura H; Adachi Y; Yoshioka T; Watanabe T; Matsushita H; Fujii T; Kondo E; Tachibe T; Kawase Y; Jishage K; Yasoda A; Mukoyama M; Nakao K
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1339-48. PubMed ID: 19808910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metal-binding domain of IGFBP-3 selectively delivers therapeutic molecules into cancer cells.
    Huq A; Singh B; Meeker T; Mascarenhas D
    Anticancer Drugs; 2009 Jan; 20(1):21-31. PubMed ID: 19342998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-binding protein-3 in osteosarcomas and normal bone tissues.
    Ressler S; Radhi J; Aigner T; Loo C; Zwerschke W; Sergi C
    Anticancer Res; 2009 Jul; 29(7):2579-87. PubMed ID: 19596932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.